Nationwide Fund Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-57,314
| Closed | -$3.05M | – | 1616 |
|
|
2017
Q3 | $3.05M | Sell |
57,314
-2,709
| -5% | -$144K | 0.01% | 1262 |
|
|
2017
Q2 | $3.73M | Buy |
60,023
+11,685
| +24% | +$726K | 0.02% | 1151 |
|
|
2017
Q1 | $3.28M | Sell |
48,338
-1,049
| -2% | -$71.1K | 0.01% | 1190 |
|
|
2016
Q4 | $3.47M | Buy |
49,387
+187
| +0.4% | +$13.1K | 0.01% | 1171 |
|
|
2016
Q3 | $3.49M | Sell |
49,200
-28,410
| -37% | -$2.02M | 0.01% | 1152 |
|
|
2016
Q2 | $3.8M | Sell |
77,610
-9,761
| -11% | -$477K | 0.02% | 1076 |
|
|
2016
Q1 | $5.56M | Buy |
87,371
+6,066
| +7% | +$386K | 0.02% | 881 |
|
|
2015
Q4 | $9.12M | Sell |
81,305
-2,105
| -3% | -$236K | 0.04% | 613 |
|
|
2015
Q3 | $8.03M | Buy |
83,410
+9,291
| +13% | +$895K | 0.04% | 632 |
|
|
2015
Q2 | $7.59M | Buy |
74,119
+16,069
| +28% | +$1.65M | 0.03% | 729 |
|
|
2015
Q1 | $3.6M | Buy |
58,050
+5,351
| +10% | +$332K | 0.01% | 1141 |
|
|
2014
Q4 | $2.31M | Buy |
52,699
+6,152
| +13% | +$270K | 0.01% | 1340 |
|
|
2014
Q3 | $2.64M | Buy |
46,547
+28,992
| +165% | +$1.64M | 0.01% | 1279 |
|
|
2014
Q2 | $788K | Buy |
17,555
+7,422
| +73% | +$333K | ﹤0.01% | 2021 |
|
|
2014
Q1 | $495K | Buy |
+10,133
| New | +$495K | ﹤0.01% | 2066 |
|